Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis
Despite the beneficial effects of pirfenidone in treating idiopathic pulmonary fibrosis (IPF), it remains unclear if lung fibroblasts (FB) are the main therapeutic target. - To resolve this question, we employed a comparative transcriptomic approach and analysed lung homogenates (LH) and FB derived...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
November 22, 2018
|
| In: |
The European respiratory journal
Year: 2018, Volume: 52, Issue: 5 |
| ISSN: | 1399-3003 |
| DOI: | 10.1183/13993003.00564-2018 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1183/13993003.00564-2018 Verlag: https://erj.ersjournals.com/content/52/5/1800564 
|
| Author Notes: | Grazyna Kwapiszewska, Anna Gungl, Jochen Wilhelm, Leigh M. Marsh, Helene Thekkekara Puthenparampil, Katharina Sinn, Miroslava Didiasova, Walter Klepetko, Djuro Kosanovic, Ralph T. Schermuly, Lukasz Wujak, Benjamin Weiss, Liliana Schaefer, Marc Schneider, Michael Kreuter, Andrea Olschewski, Werner Seeger, Horst Olschewski and Malgorzata Wygrecka |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1681376474 | ||
| 003 | DE-627 | ||
| 005 | 20220817020846.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191107s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1183/13993003.00564-2018 |2 doi | |
| 035 | |a (DE-627)1681376474 | ||
| 035 | |a (DE-599)KXP1681376474 | ||
| 035 | |a (OCoLC)1341250466 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kwapiszewska-Marsh, Grazyna |d 1977- |e VerfasserIn |0 (DE-588)131700073 |0 (DE-627)707710871 |0 (DE-576)29868313X |4 aut | |
| 245 | 1 | 0 | |a Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis |c Grazyna Kwapiszewska, Anna Gungl, Jochen Wilhelm, Leigh M. Marsh, Helene Thekkekara Puthenparampil, Katharina Sinn, Miroslava Didiasova, Walter Klepetko, Djuro Kosanovic, Ralph T. Schermuly, Lukasz Wujak, Benjamin Weiss, Liliana Schaefer, Marc Schneider, Michael Kreuter, Andrea Olschewski, Werner Seeger, Horst Olschewski and Malgorzata Wygrecka |
| 264 | 1 | |c November 22, 2018 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.11.2019 | ||
| 520 | |a Despite the beneficial effects of pirfenidone in treating idiopathic pulmonary fibrosis (IPF), it remains unclear if lung fibroblasts (FB) are the main therapeutic target. - To resolve this question, we employed a comparative transcriptomic approach and analysed lung homogenates (LH) and FB derived from IPF patients treated with or without pirfenidone. - In FB, pirfenidone therapy predominantly affected growth and cell division pathways, indicating a major cellular metabolic shift. In LH samples, pirfenidone treatment was mostly associated with inflammation-related processes. In FB and LH, regulated genes were over-represented in the Gene Ontology node “extracellular matrix”. We identified lower expression of cell migration-inducing and hyaluronan-binding protein (CEMIP) in both LH and FB from pirfenidone-treated IPF patients. Plasma levels of CEMIP were elevated in IPF patients compared to healthy controls and decreased after 7 months of pirfenidone treatment. CEMIP expression in FB was downregulated in a glioma-associated oncogene homologue-dependent manner and CEMIP silencing in IPF FB reduced collagen production and attenuated cell proliferation and migration. - Cumulatively, our approach indicates that pirfenidone exerts beneficial effects via its action on multiple pathways in both FB and other pulmonary cells, through its ability to control extracellular matrix architecture and inflammatory reactions. - Tweetable abstract ERSpublications - click to tweetPirfenidone's mode of action in human lungs involves a complex interactome comprising genes related to inflammation and extracellular matrix architecture http://ow.ly/26NN30lpGON | ||
| 700 | 1 | |a Kreuter, Michael |d 1972- |e VerfasserIn |0 (DE-588)122645995 |0 (DE-627)082066795 |0 (DE-576)293362742 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The European respiratory journal |d Lausanne : ERS, 1988 |g 52(2018,5), Artikel-Nummer 1800564, 14 Seiten |h Online-Ressource |w (DE-627)306646803 |w (DE-600)1499101-9 |w (DE-576)091142504 |x 1399-3003 |7 nnas |a Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis |
| 773 | 1 | 8 | |g volume:52 |g year:2018 |g number:5 |g extent:14 |a Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis |
| 856 | 4 | 0 | |u https://doi.org/10.1183/13993003.00564-2018 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://erj.ersjournals.com/content/52/5/1800564 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191107 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 122645995 |a Kreuter, Michael |m 122645995:Kreuter, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PK122645995 |e 950000PK122645995 |e 950900PK122645995 |e 50000PK122645995 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 14 | ||
| 999 | |a KXP-PPN1681376474 |e 3538245894 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1681376474","note":["Gesehen am 07.11.2019"],"relHost":[{"disp":"Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosisThe European respiratory journal","language":["eng"],"name":{"displayForm":["European Respiratory Society"]},"origin":[{"publisher":"ERS ; Munksgaard","dateIssuedDisp":"1988-","publisherPlace":"Lausanne ; Copenhagen","dateIssuedKey":"1988"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"European respiratory journal","title":"The European respiratory journal","subtitle":"flagship scientific journal of ERS"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1988 -"],"part":{"text":"52(2018,5), Artikel-Nummer 1800564, 14 Seiten","year":"2018","extent":"14","volume":"52","issue":"5"},"recId":"306646803","note":["Gesehen am 25.04.2025","Fortsetzung der Druck-Ausgabe"],"corporate":[{"display":"European Respiratory Society","role":"isb","roleDisplay":"Herausgebendes Organ"}],"id":{"issn":["1399-3003"],"eki":["306646803"],"zdb":["1499101-9"]},"titleAlt":[{"title":"official journal of the European Society for Clinical Respiratory Physiology : ERJ"},{"title":"ERJ"}]}],"name":{"displayForm":["Grazyna Kwapiszewska, Anna Gungl, Jochen Wilhelm, Leigh M. Marsh, Helene Thekkekara Puthenparampil, Katharina Sinn, Miroslava Didiasova, Walter Klepetko, Djuro Kosanovic, Ralph T. Schermuly, Lukasz Wujak, Benjamin Weiss, Liliana Schaefer, Marc Schneider, Michael Kreuter, Andrea Olschewski, Werner Seeger, Horst Olschewski and Malgorzata Wygrecka"]},"id":{"eki":["1681376474"],"doi":["10.1183/13993003.00564-2018"]},"origin":[{"dateIssuedDisp":"November 22, 2018","dateIssuedKey":"2018"}],"physDesc":[{"extent":"14 S."}],"language":["eng"],"person":[{"given":"Grazyna","role":"aut","roleDisplay":"VerfasserIn","display":"Kwapiszewska-Marsh, Grazyna","family":"Kwapiszewska-Marsh"},{"display":"Kreuter, Michael","given":"Michael","roleDisplay":"VerfasserIn","role":"aut","family":"Kreuter"}],"title":[{"title":"Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis","title_sort":"Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis"}]} | ||
| SRT | |a KWAPISZEWSTRANSCRIPT2220 | ||